“Benign melanoma”: understanding the terminology

Someone may use the phrase informally when a spot was suspected to be melanoma but testing found a benign naevus, lentigo or another non-cancerous lesion. The final clinical or pathology term is the one that should guide care.

A dermatologist considers whether a lesion is new or changing, examines its symmetry, borders, colours and structure, and may use a dermoscope for a magnified view. Not every melanoma follows a classic visual pattern, and benign lesions can look irregular.

When melanoma cannot be excluded, a biopsy allows a pathologist to examine the cells and their arrangement. The report may describe a benign naevus, an atypical lesion, melanoma in situ or invasive melanoma; these terms have different implications and should not be used interchangeably.

Ask for the exact diagnosis in writing if you were told only that a lesion was “benign melanoma.” If a pathology report exists, review it with the clinician who removed or sampled the lesion and clarify whether further excision or routine skin monitoring is advised.

Check your skin regularly in good light, including the scalp, nails, soles and areas that are difficult to see. Photographs can help show genuine change. Protect skin from ultraviolet exposure with shade, clothing and suitable sunscreen, and avoid tanning devices.

Arrange a timely skin examination for a new or changing spot, especially one that becomes asymmetric, develops an irregular edge or varied colours, grows, bleeds, crusts, itches persistently or does not heal. A mark that looks distinctly different from your other moles also merits attention.

These changes can occur for several reasons and do not diagnose melanoma on their own. If melanoma has already been confirmed, follow the skin-cancer team's plan and report new symptoms or changing lesions without waiting for a routine appointment.

Ask whether the diagnosis is fully benign, atypical, in situ or invasive; whether the specimen edges are clear; and whether more surgery is recommended. If invasive melanoma is present, ask which pathology features determine staging, whether lymph-node assessment is relevant and how follow-up will be organised.